CDKN1B and cancer: Cyclin‐dependent kinase inhibitor 1B (CDKN1B), also named p27kip1, has been reported to inhibit cell cycle progression G1–S transitions, and phosphorylation of CDKN1B at different sites altered its distribution in the nucleus and cytoplasm in different cancers 11, 12.